Indonesia takes part in late-stage China vaccine trial

The Indonesian government announced the partnership between state-owned enterprise Bio Farma and the Chinese company Sinovac BioTech in early July. As part of the deal, Indonesia recruited 1,620 volunteers for the trial. The first 20 were injected with the candidate vaccine in Bandung, West Java province, on Tuesday, and more followed suit.

Pfizer’s Covid-19 vaccine successfully provokes immune response in early clinical study raising hope for the jab already ordered by UK officials

Results published May 22 in The Lancet showed most of the people dosed with the vaccine had immune responses, although their levels of antibodies thought to neutralize the virus were relatively low. Researchers saw a stronger ramp-up of other immune compounds, called T-cells, that might also help fight the infection off.   

Making a Covid-19 Vaccine Is Hard. Making One for Kids Is Harder

But where does that leave kids? So far, mostly out of the vaccine equation, Permar says, in a way that doesn’t totally add up. In part, that has to do with all the usual hurdles of pediatric research: Kids are harder to enroll in studies, due to safety and ethics concerns, and their maturing immune […]

Exclusive: U.S. to make coronavirus strain for possible human challenge trials

Dr. Dan Barouch, a vaccine researcher at Harvard’s Beth Israel Deaconess Medical Center in Boston, who helped design and conduct animal studies on J&J’s COVID-19 vaccine, said he is not aware of any manufacturers planning human challenge studies.

Vaccine makers including Moderna must hit U.S. timing goals for full payments

The United States has allocation agreements with Johnson & Johnson (JNJ.N), Pfizer Inc (PFE.N), BioNTech SE (22UAy.F), Sanofi SA, and GlaxoSmithKline Plc (GSK.L). It also has a claim on 300 million doses of AstraZeneca Plc’s vaccine in exchange for helping finance its research and development efforts.

Top U.S. health official says approval of COVID vaccines unlikely before November

“I would not expect to see, on the basis of what we know scientifically, that we would be at the point where the FDA could make such a judgment until considerably later than October 1st,” Collins said, referring to the U.S. Food and Drug Administration. “Maybe November or December would be my best bet.”

Covid-19: Nigeria studying Russia’s claim of vaccine —FG

He said: “We are concerned by the resurgence of infection in healthcare workers. In a bid to sustain the gains we have made in reducing the rate of infection among our health workers, we have embarked on training and retraining of health workers on infection prevention and control.

COVID-19: Rahul Gandhi urges Centre to formulate well-defined vaccine access policy

On Thursday, Mr. Gandhi posted an animated graphic that showed India soaring past United States and Brazil in terms of registering daily new cases, against the Prime Minister’s statement that the situation in India has been ‘manageable’ to a great extent because of acting on time.

Russia’s top respiratory doctor quits over ‘gross violations’ of medical ethics that rushed through Putin’s coronavirus ‘vaccine’

Russia has made the vaccine race a matter of national prestige and has named the product ‘Sputnik V’ after the former Soviet space satellites, prompting fears that safety will be compromised for the sake of Russia’s image. 

Russian vaccine not in advanced test stages, says WHO

WHO and partners have included nine experimental Covid-19 vaccines within an investment mechanism it is encouraging countries to join, known as the Covax facility. The initiative allows countries to invest in several vaccines to obtain early access, while theoretically providing funding for developing countries.